Natural products are the greatest source of antimicrobial agents, although their structural complexity often renders synthetic production and diversification of key classes impractical. One pertinent example is the glycopeptide antibiotics (GPAs), which are highly challenging to synthesize due to their heavily cross-linked structures. Here, we report an optimized method that generates >75% tricyclic peptides from synthetic precursors in order to explore the acceptance of novel GPA precursor peptides by these key existent biosynthetic enzymes
The glycopeptide antibiotics are important clinical antibiotics that are currently employed against ...
AbstractBackground: The glycopeptide antibiotics vancomycin and teicoplanin are currently the last l...
Natural peptide products are a valuable source of important therapeutic agents, including antibiotic...
Non-ribosomal peptides contain an array of amino acid building blocks that can present challenges fo...
Natural products such as the glycopeptide antibiotics (GPAs, including vancomycin and teicoplanin) a...
Non-ribosomal peptides contain an array of amino acid building blocks that can present challenges fo...
Modification of natural product backbones is a proven strategy for the development of clinically use...
Since the discovery of vancomycin in the 1950s, the glycopeptide antibiotics (GPAs) have been of gre...
The glycopeptide antibiotics are an important class of complex, medically relevant peptide natural p...
The glycopeptide antibiotics are an important class of complex, medically relevant peptide natural p...
Understanding the mechanisms underpinning glycopeptide antibiotic biosynthesis is key to the future ...
Nonribosomal peptide synthesis is capable of utilizing a wide range of amino acid residues due to th...
Expansion of the chemical diversity of glycopeptide antibiotics (GPAs) to deal with the emergence an...
The biosynthesis of the glycopeptide antibiotics (GPAs) - which include teicoplanin and vancomycin -...
Non-ribosomal peptide synthesis is a highly important biosynthetic pathway for the formation of many...
The glycopeptide antibiotics are important clinical antibiotics that are currently employed against ...
AbstractBackground: The glycopeptide antibiotics vancomycin and teicoplanin are currently the last l...
Natural peptide products are a valuable source of important therapeutic agents, including antibiotic...
Non-ribosomal peptides contain an array of amino acid building blocks that can present challenges fo...
Natural products such as the glycopeptide antibiotics (GPAs, including vancomycin and teicoplanin) a...
Non-ribosomal peptides contain an array of amino acid building blocks that can present challenges fo...
Modification of natural product backbones is a proven strategy for the development of clinically use...
Since the discovery of vancomycin in the 1950s, the glycopeptide antibiotics (GPAs) have been of gre...
The glycopeptide antibiotics are an important class of complex, medically relevant peptide natural p...
The glycopeptide antibiotics are an important class of complex, medically relevant peptide natural p...
Understanding the mechanisms underpinning glycopeptide antibiotic biosynthesis is key to the future ...
Nonribosomal peptide synthesis is capable of utilizing a wide range of amino acid residues due to th...
Expansion of the chemical diversity of glycopeptide antibiotics (GPAs) to deal with the emergence an...
The biosynthesis of the glycopeptide antibiotics (GPAs) - which include teicoplanin and vancomycin -...
Non-ribosomal peptide synthesis is a highly important biosynthetic pathway for the formation of many...
The glycopeptide antibiotics are important clinical antibiotics that are currently employed against ...
AbstractBackground: The glycopeptide antibiotics vancomycin and teicoplanin are currently the last l...
Natural peptide products are a valuable source of important therapeutic agents, including antibiotic...